MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 77 filers reported holding MERSANA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $270,812 | -90.8% | 65,891 | -86.9% | 0.00% | -90.0% |
Q4 2022 | $2,948,430 | +8.0% | 503,145 | +24.6% | 0.02% | -9.1% |
Q3 2022 | $2,729,000 | +1027.7% | 403,687 | +164.0% | 0.02% | +633.3% |
Q3 2019 | $242,000 | -64.2% | 152,904 | -8.4% | 0.00% | -66.7% |
Q2 2019 | $676,000 | +327.8% | 166,883 | +331.4% | 0.01% | +200.0% |
Q4 2018 | $158,000 | – | 38,681 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |